Crossmark

The distribution and clinical significance of anti-nuclear antibodies in patients with idiopathic inflammatory myopathy in Southwest China

Crossref DOI link: https://doi.org/10.1016/j.medcli.2025.107273

Published Print: 2026-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Guo, Yixue

Liu, Hongjiang

Zhang, Keyi

Meng, Liye

Niu, Qian

Zhang, Junlong

Xie, Qibing

Huang, Zhuochun
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82272400)

National Key Research and Development Program of China Stem Cell and Translational Research

National Key Research and Development Program of China (2022YFC2406600)

National Key Research and Development Program of China (2022YFC2406604)
License Information

Text and Data Mining valid from 2026-01-01

Text and Data Mining valid from 2026-01-01

stm-asf valid from 2026-01-01

stm-asf valid from 2026-01-01

stm-asf valid from 2026-01-01

stm-asf valid from 2026-01-01

stm-asf valid from 2026-01-01
More Information

This article is maintained by: Elsevier

Article Title: The distribution and clinical significance of anti-nuclear antibodies in patients with idiopathic inflammatory myopathy in Southwest China

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2025.107273

Content Type: article

Copyright: © 2025 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.